B25.2 Cytomegaloviral pancreatitis

Name of the Condition

• Cytomegaloviral pancreatitis

Summary

Cytomegaloviral pancreatitis is an inflammation of the pancreas caused by the cytomegalovirus (CMV), a member of the Herpesviridae family. It primarily affects individuals with weakened immune systems, leading to pancreatic dysfunction and related symptoms. The condition can range from mild to severe, with outcomes depending on the extent of pancreatic involvement and the patient's immune status.

Causes

The inflammation is caused by the cytomegalovirus (CMV), which is transmitted through direct contact with infected bodily fluids (e.g., saliva, urine, blood, or respiratory secretions). Primary infection occurs when the virus enters the body, and reactivation can happen in immunocompromised individuals. Congenital transmission from mother to fetus during pregnancy is also possible.

Risk Factors

• Immunocompromised states, including HIV/AIDS, organ transplantation, or immunosuppressive therapy.
• Neonates and infants, particularly those born to mothers with primary CMV infection during pregnancy.
• Close contact with individuals shedding the virus (e.g., in healthcare or daycare settings).
• Advanced age, which may be associated with declining immune function.

Symptoms

• Abdominal pain (often in the upper abdomen, radiating to the back).
• Nausea and vomiting.
• Fever.
• Loss of appetite.
• Weight loss.
• Jaundice (in severe cases).

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests may detect CMV antibodies or DNA, while pancreatic enzyme levels (e.g., amylase, lipase) help assess inflammation. Imaging studies, such as CT or MRI, can visualize pancreatic changes. In some cases, a biopsy may confirm viral presence and tissue damage.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying infection. Antiviral medications (e.g., ganciclovir, valganciclovir) may be used in immunocompromised patients. Supportive care includes pain management, fluid replacement, and nutritional support. Severe cases may require hospitalization for monitoring and intervention.

Prognosis and Follow-Up

Prognosis depends on the patient's immune status and the severity of pancreatic involvement. Immunocompetent individuals often recover fully, while immunocompromised patients may experience prolonged or recurrent episodes. Follow-up includes monitoring pancreatic function and viral load, with adjustments to treatment as needed.

Complications

• Pancreatic necrosis or abscess formation.
• Chronic pancreatitis.
• Malabsorption due to impaired pancreatic enzyme production.
• Systemic spread of the virus to other organs.

Lifestyle & Prevention

• Practice good hygiene, including handwashing, to reduce exposure to infected bodily fluids.
• Avoid close contact with individuals known to have active CMV infection, especially if immunocompromised.
• For high-risk groups (e.g., transplant recipients), follow medical guidance on prophylactic antiviral therapy.
• Maintain overall immune health through balanced nutrition and regular medical care.

When to Seek Professional Help

Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, high fever, or signs of jaundice. These symptoms may indicate serious pancreatic involvement requiring urgent evaluation and treatment.

Tips for Medical Coders

When coding for cytomegaloviral pancreatitis (B25.2), ensure documentation supports the diagnosis, including clinical findings, laboratory results, and imaging studies. Note the patient's immune status, as this may influence coding specificity. Avoid using this code for unrelated pancreatic conditions or non-viral causes of pancreatitis. Verify that the code aligns with the documented etiology and clinical presentation.